{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:27:21Z","timestamp":1769164041169,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.mehy.2010.09.020","type":"journal-article","created":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T08:46:36Z","timestamp":1288082796000},"page":"311-313","source":"Crossref","is-referenced-by-count":11,"title":["(\u2212)-Epigallocatechin 3-gallate (EGCG) at the ocular surface inhibits corneal neovascularization"],"prefix":"10.1016","volume":"76","author":[{"given":"V.","family":"S\u00e1nchez-Huerta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Guti\u00e9rrez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Flores-Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2010.09.020_b0005","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.mehy.2010.09.020_b0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000099253","article-title":"Immune privilege and angiogenic privilege of the cornea","volume":"92","author":"Cursiefen","year":"2007","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.mehy.2010.09.020_b0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2353\/ajpath.2010.080642","article-title":"Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo","volume":"176","author":"Ebrahem","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2010.09.020_b0020","unstructured":"Azar DT. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2006;104:264\u2013302."},{"key":"10.1016\/j.mehy.2010.09.020_b0025","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1167\/iovs.08-2732","article-title":"Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist","volume":"50","author":"Lu","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2010.09.020_b0030","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1167\/iovs.08-1897","article-title":"Inhibition by a selective IkappaB kinase-2 inhibitor of interleukin-1-induced collagen degradation by corneal fibroblasts in three-dimensional culture","volume":"49","author":"Kondo","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2010.09.020_b0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.exer.2004.04.008","article-title":"Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization","volume":"79","author":"Castro","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.mehy.2010.09.020_b0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/tx990003t","article-title":"Antioxidant chemistry of green tea catechins. Identification of products of the reaction of (\u2212)-epigallocatechin gallate with peroxyl radicals","volume":"12","author":"Valcic","year":"1999","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.mehy.2010.09.020_b0045","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.4049\/jimmunol.170.8.4335","article-title":"Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis","volume":"170","author":"Don\u00e0","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2010.09.020_b0050","doi-asserted-by":"crossref","unstructured":"Fujiki H. Green tea: health benefits as cancer preventive for humans. Chem Rec 2005;5:119\u201332.","DOI":"10.1002\/tcr.20039"},{"key":"10.1016\/j.mehy.2010.09.020_b0055","doi-asserted-by":"crossref","first-page":"373S","DOI":"10.1080\/07315724.2007.10719626","article-title":"Effects of green tea and EGCG on cardiovascular and metabolic health","volume":"26","author":"Wolfram","year":"2007","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.mehy.2010.09.020_b0060","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/ijms9061034","article-title":"Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG","volume":"9","author":"Shimizu","year":"2008","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mehy.2010.09.020_b0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.lfs.2008.11.018","article-title":"Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7","volume":"84","author":"Sen","year":"2009","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2010.09.020_b0070","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/ijc.21545","article-title":"Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex","volume":"118","author":"Rodriguez","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.mehy.2010.09.020_b0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jnutbio.2006.11.001","article-title":"Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells","volume":"18","author":"Kim","year":"2007","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.mehy.2010.09.020_b0080","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/art.10443","article-title":"Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB","volume":"46","author":"Singh","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2010.09.020_b0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopha.2005.01.004","article-title":"Repressions of MMP-9 expression and NF-kappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (\u2212)-epigallocatechin-3-gallate","volume":"59","author":"Yang","year":"2005","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.mehy.2010.09.020_b0090","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/jn\/132.7.1836","article-title":"Physiological concentrations of (\u2212)-epigallocatechin-3-O-gallate (EGCG) prevent chromosomal damage induced by reactive oxygen species in WIL2-NS cells","volume":"132","author":"Sugisawa","year":"2002","journal-title":"J Nutr"},{"key":"10.1016\/j.mehy.2010.09.020_b0095","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fct.2005.11.003","article-title":"Safety studies on epigallocatechin gallate (EGCG) preparation. Part 2: dermal, acute and short-term toxicity studies","volume":"44","author":"Isbrucker","year":"2006","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.mehy.2010.09.020_b0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1006\/exer.2000.0900","article-title":"Treatment of corneal neovascularization with dietary isoflavonoids and flavonoids","volume":"71","author":"Joussen","year":"2000","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.mehy.2010.09.020_b0105","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000126081","article-title":"Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo","volume":"222","author":"Bian","year":"2008","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.mehy.2010.09.020_b0110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/18793","article-title":"Angiogenesis inhibited by drinking tea","volume":"398","author":"Cao","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2010.09.020_b0115","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2353\/ajpath.2007.070172","article-title":"Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis","volume":"171","author":"Nakao","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2010.09.020_b0120","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/14656561003667532","article-title":"Loteprednol and tobramycin in combination: a review of their impact on current treatment regimens","volume":"11","author":"Comstock","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.mehy.2010.09.020_b0125","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","article-title":"Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization","volume":"247","author":"Koenig","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.mehy.2010.09.020_b0130","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archopht.125.6.834","article-title":"Topical bevacizumab therapy for corneal neovascularization","volume":"125","author":"DeStafeno","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.mehy.2010.09.020_b0135","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1349-7006.2008.00853.x","article-title":"Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy","volume":"99","author":"Ono","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.mehy.2010.09.020_b0140","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1080\/10611860600992157","article-title":"Non-systemic delivery of topical brimonidine to the brain: a neuro-ocular tissue distribution study","volume":"14","author":"Abdulrazik","year":"2006","journal-title":"J Drug Target"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987710003865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987710003865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T22:03:15Z","timestamp":1559772195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987710003865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0306987710003865"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2010.09.020","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}